Rare Case of Recurrent Adamantinoma of the Tibia: Limited Efficacy of Pazopanib as a Standalone Treatment

Mahmoud Elshenawy; Sarah Khaled Aldahoul; Abduljalil Mohamed El-Sibai; Alaa Hamad; Tarek Ziad Arabi; Saleha Abdul Rab; Ahmed Badran; Tariq Alzaid; Belal Nedal Sabbah; Jean Paul Atallah

doi:10.12659/AJCR.941248

15 March 2024 : Case report Saudi Arabia

Rare Case of Recurrent Adamantinoma of the Tibia: Limited Efficacy of Pazopanib as a Standalone Treatment

Unusual or unexpected effect of treatment, Rare disease

Mahmoud Elshenawy^12ADE, Sarah Khaled Aldahoul^3EF, Abduljalil Mohamed El-Sibai^3EF, Alaa Hamad^3EF, Tarek Ziad Arabi^3ADEF*, Saleha Abdul Rab^3EF, Ahmed Badran^45ADE, Tariq Alzaid^6DE, Belal Nedal Sabbah^3E, Jean Paul Atallah^4ADE

DOI: 10.12659/AJCR.941248

Am J Case Rep 2024; 25:e941248

Authors information Article notes Copyright and License information

Introduction Case Report Discussion Conclusions References:

Related articles Order reprints Share article Share by email

View HTML version

Figure 4. Axial computed tomography revealing a large malignant pelvic mass (arrows) before surgery at presentation (A), after surgery (B), and after pazopanib (C).

Back to the Article

Rare Case of Recurrent Adamantinoma of the Tibia: Limited Efficacy of Pazopanib as a Standalone Treatment

Your Privacy